Bio View (XTAE:BIOV) EV-to-Revenue : 1.49 (As of May. 28, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Bio View EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bio View's enterprise value is ₪24.84 Mil. Bio View's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪16.65 Mil. Therefore, Bio View's EV-to-Revenue for today is 1.49.

The historical rank and industry rank for Bio View's EV-to-Revenue or its related term are showing as below:

XTAE:BIOV' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.13 Med: 1.18 Max: 7.5
Current: 1.5

During the past 13 years, the highest EV-to-Revenue of Bio View was 7.50. The lowest was 0.13. And the median was 1.18.

XTAE:BIOV's EV-to-Revenue is ranked better than
74.13% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.25 vs XTAE:BIOV: 1.50

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Bio View's stock price is ₪0.287. Bio View's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.12. Therefore, Bio View's PS Ratio for today is 2.35.

Bio View EV-to-Revenue Historical Data

The historical data trend for Bio View's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View EV-to-Revenue Chart

Bio View Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.75

1.55

1.02

1.24

0.88

Bio View Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															1.33	1.37	1.24	2.06	0.88

Competitive Comparison of Bio View's EV-to-Revenue

For the Medical Devices subindustry, Bio View's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio View's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio View's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bio View's EV-to-Revenue falls into.

Bio View EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bio View's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	24.842	/	16.65
	=	1.49

Bio View's current Enterprise Value is ₪24.84 Mil.
Bio View's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪16.65 Mil.

Bio View (XTAE:BIOV) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bio View's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.287	/	0.122
	=	2.35

Bio View's share price for today is ₪0.287.
Bio View's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.12.

Bio View EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio View's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio View (XTAE:BIOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Pekeris Street, Rehovot, ISR, 7670203

Website

http://www.bioview.co.il

Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View (XTAE:BIOV) Headlines

No Headlines